Figure 7.
Sensitivity of low- or high-risk patients to five common chemotherapy agents. The y-axis represents 50% inhibitory concentration (IC50). (A) Bexarotene; (B) Bicalutamide; (C) Bortezomib; (D) Bryostatin; (E) Rapamycin.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.